13.21
전일 마감가:
$14.60
열려 있는:
$13.95
하루 거래량:
1.71M
Relative Volume:
1.61
시가총액:
$11.04B
수익:
$3.85B
순이익/손실:
$667.93M
주가수익비율:
20.10
EPS:
0.657
순현금흐름:
$142.30M
1주 성능:
-11.16%
1개월 성능:
-5.44%
6개월 성능:
-5.24%
1년 성능:
-12.11%
Dr Reddys Laboratories Ltd Adr Stock (RDY) Company Profile
명칭
Dr Reddys Laboratories Ltd Adr
전화
-
주소
-
RDY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
RDY
Dr Reddys Laboratories Ltd Adr
|
13.22 | 12.15B | 3.85B | 667.93M | 142.30M | 0.657 |
|
ZTS
Zoetis Inc
|
145.72 | 64.44B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.92 | 44.53B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.105 | 40.61B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.45 | 22.69B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
459.12 | 18.78B | 3.08B | 1.24B | 1.07B | 25.61 |
Dr Reddys Laboratories Ltd Adr Stock (RDY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-05 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-12-19 | 다운그레이드 | Nomura | Buy → Neutral |
| 2024-01-11 | 다운그레이드 | Jefferies | Buy → Underperform |
| 2023-08-29 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2023-05-18 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2023-03-17 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-01-30 | 개시 | JP Morgan | Underweight |
| 2022-11-14 | 다운그레이드 | Credit Suisse | Neutral → Underperform |
| 2022-01-03 | 재개 | BofA Securities | Neutral |
| 2021-07-27 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2021-02-02 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-09-18 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-09-18 | 업그레이드 | Investec | Sell → Hold |
| 2020-01-28 | 다운그레이드 | CLSA | Buy → Outperform |
| 2020-01-27 | 다운그레이드 | CLSA | Buy → Outperform |
| 2020-01-09 | 업그레이드 | Citigroup | Sell → Buy |
| 2019-11-04 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-09-04 | 업그레이드 | Credit Suisse | Underperform → Outperform |
| 2019-07-01 | 업그레이드 | Macquarie | Neutral → Outperform |
| 2019-06-20 | 개시 | Deutsche Bank | Hold |
| 2019-06-11 | 개시 | Barclays | Equal Weight |
| 2019-05-20 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2019-02-19 | 업그레이드 | CLSA | Outperform → Buy |
| 2019-01-17 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2017-09-21 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2017-08-31 | 업그레이드 | CLSA | Underperform → Outperform |
| 2017-07-28 | 다운그레이드 | CLSA | Underperform → Sell |
| 2016-07-27 | 다운그레이드 | HSBC Securities | Hold → Reduce |
| 2016-07-27 | 다운그레이드 | Jefferies | Hold → Underperform |
| 2016-02-10 | 업그레이드 | Credit Agricole | Underperform → Buy |
| 2015-11-10 | 다운그레이드 | Citigroup | Buy → Neutral |
모두보기
Dr Reddys Laboratories Ltd Adr 주식(RDY)의 최신 뉴스
Dr Reddys ADR Slumps 10% After Bid To Launch Weight-Loss Drug In Canada Hits Regulatory Hurdle - NDTV Profit
Asian ADRs See Mixed Results With Fintech In Focus - Finimize
Dr. Reddy’s Labs ADR earnings beat, revenue topped estimates By Investing.com - Investing.com Australia
Dr. Reddy’s Labs ADR earnings beat, revenue topped estimates - Investing.com India
Asian Stocks See Gains In US Trading This Week - Finimize
Asian ADRs Kept Steady As Investors Pick Favorites - Finimize
Asian Stocks Climb In The US As Big Names Rally - Finimize
Infosys Q2 results out! Here’s what experts, Infosys ADR signal about stock price - Mint
Asian ADRs Stay Calm As Individual Stocks Swing Both Ways - Finimize
Dr. Reddy's Laboratories Ltd Common Stock (NY: - FinancialContent
Full Truck Alliance Co. Ltd. Sponsored ADR $YMM Shares Purchased by Mirae Asset Global Investments Co. Ltd. - Defense World
Corporacion Inmobiliaria Vesta, S.A.B. de C.V. Sponsored ADR (NYSE:VTMX) Receives $31.33 Consensus Target Price from Analysts - Defense World
Asian Stocks In The US Closed Lower This Week - Finimize
Cash per share of Dr. Reddy's Laboratories Ltd. Sponsored ADR – NYSE:RDY - TradingView
Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs - Benzinga
Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs - Sahm
HB Wealth Management LLC Takes $181,000 Position in Dr. Reddy’s Laboratories Ltd $RDY - Defense World
Robeco Institutional Asset Management B.V. Buys 1,452,192 Shares of Dr. Reddy's Laboratories Ltd $RDY - MarketBeat
Asian ADRs Rise As Regional Firms Show Mixed Performance - Finimize
LLY Stock Quote Price and Forecast - CNN
Dr Reddys Share Price Update: Company Reports Negative Monthly Returns - Meyka
Dr. Reddy's Laboratories Ltd $RDY Shares Bought by Ballentine Partners LLC - MarketBeat
GDR, ADR & IDR Companies Stock Prices | IIFL Capital - India Infoline
NVO Stock Quote Price and Forecast - CNN
Asian ADRs In The US Start The Week On A High Note - Finimize
Bizarre Stock Volatility? How Is H1B News Affecting Infosys & Wipro Share Prices On Saturday? - Free Press Journal
Asian ADR Index Edges Up As LG Display Leads - Finimize
Dr. Reddy’s Laboratories Allots Equity Shares Under Employee Stock Option Scheme - The Globe and Mail
Dr Reddy's shares fall as USFDA flags Hyderabad plant with 5 observations - Business Standard
Asian ADRs Gain As Investors Show Renewed Interest - Finimize
Asian Equities In The US Logged Broad Gains This Session - Finimize
Mixed Performance For Asian Stocks Traded In The US - Finimize
Dr. Reddy’s Laboratories Allots Equity Shares to Employees - TipRanks
Invesco Ltd. Has $8.12 Million Stake in ATRenew Inc. Sponsored ADR $RERE - Defense World
Validea's Top Health Care Stocks Based On Peter Lynch8/25/2025 - Nasdaq
Coya Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Application for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) - Barchart.com
Wall Street today: Dow, Nasdaq, S&P drop as investors exercise caution ahead of US Fed's Jackson Hole meeting - Mint
Dr Reddys Laboratories Ltd Adr (RDY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):